J.P.Morgan Software Investment Banking

Strategics buyer insights - IQVIA JPMorgan relationship Strategic rationale Notable M&A deals Ari Bousbib Chairman & CEO · Q²Solutions . Combination of leading end-to-end data & analytics solutions for clinical research with the industry's largest primary-source real world data repository Meaningful synergy potential across key life sciences verticals • Unmatched scale across key healthcare constituents with significant cross-sell potential Apr ¹21 $1.9bn Clinical lab services J.P.Morgan Company filings: press releases: FactSet as of 4/19/21 Note: All transaction multiples reffect NTM, unless noted otherwise Quintiles MS™ Key decision makers May '16 $23.0bn Merger of equals Ron Bruehlman CFO imshealth April '14 $1.3bn Initial public offering J.P.Morgan QUINTILES Market cap: $45.1bn FV / 22E Rev.: 3.9x FV / '22E uFCF: 27.8x May '13 $0.9bn Initial public offering J.P.Morgan 44

View entire presentation